Tirzepatide mg:15mg x 10 vialsTirzepatide Peptide Dual GIP GLP 1 Agonist 99% Ultra Pure for Fat Loss, Insulin Sensitivity & Metabolic Research Elevate your research with Tirzepatide a cutting edge dual incretin receptor agonist that activates both GLP 1 and GIP receptors. This breakthrough compound is reshaping the landscape of obesity, insulin resistance, and type 2 diabetes studies. Now available in 99% HPLC tested purity, Tirzepatide provides exceptional consistency and
Semaglutide Peptide – Ultra-Pure 99% | Advanced GLP-1 Agonist for Fat Loss & Metabolic Research
Important Notice
glucose regulation
Superior Fat Loss PotentialEarly data suggests greater weight reduction and improved glycemic control compared to GLP-1-only peptides
and Glucagon pathways for amplified fat-burning
mimicking once-weekly dosing protocols for efficiency in preclinical studies
and type 2 diabetes studies
Pharmaceutical-Grade Purity (99%)Independently verified via HPLC—minimizing impurities and maximizing research precision
and insulin sensitivity
Insulin sensitivity and glycemic control models
and appetite control
ensuring research-grade quality and dependable lab outcomes